Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.666, 2012-01, pp. : 1-1
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Adherence to antipsychotics low despite health, cost benefits
Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. :
Access to resources
Recommend
Recognition of bipolar disorder relieves substantial cost burden
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 442, 2003-01 ,pp. :
Potential for high clinical, cost burden with MRSA
Inpharma, Vol. 1, Iss. 1459, 2004-01 ,pp. :
Cost burden of stroke hits home in the UK
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 405, 2003-01 ,pp. :
Hepatitis B significant cost burden in Asia
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 431, 2003-01 ,pp. :